Research Article

High Gastrointestinal Colonization Rate of Vancomycin-Resistant Enterococci among Hospitalized Patients: Potential Source for Resistant Gene

Table 6

Antimicrobial susceptibility patterns of Enterococci among patients admitted at HUCSH, Sidama, 2021 (N = 141).

Antimicrobial agentsOver all AST profile n (%)AST profile of E. faecalis n (%)AST profile of E. faecium n (%)
SusceptibleIntermediateResistantSusceptibleIntermediateResistantSusceptibleIntermediateResistant

Penicillin61 (43.3)80 (56.7)56 (86.2)9 (13.8)5 (6.6)71 (93.4)
Ampicillin65 (46.1)76 (53.9)65 (18)76 (18)
Erythromycin17 (12.1)35 (24.8)89 (63.1)15 (23.1)25 (38.5)25 (38.5)2 (2.6)10 (13.2)64 (84.2)
Tetracycline32 (22.7)10 (7.1)99 (70.2)27 (41.5)6 (9.2)32 (49.3)5 (6.6)4 (5.2)67 (88.2)
Chloramphenicol124 (87.9)8 (5.7)9 (6.4)62 (95.4)1 (1.5)2 (3.1)62 (81.6)7 (9.2)7 (9.2)
Linezolid139 (98.6)2 (1.4)65 (18)74 (97.4)2 (2.6)
Ciprofloxacin37 (26.2)45 (32)59 (41.8)29 (44.6)30 (46.2)6 (9.2)8 (10.5)15 (19.7)53 (69.7)
Vancomycin115 (81.6)26 (18.4)63 (96.9)2 (3.1)52 (69.4)24 (31.6)

AST = antibiotic susceptibility testing.